What is Iterative Health?
Iterative Health is a healthcare technology firm dedicated to enhancing gastrointestinal care by leveraging artificial intelligence and machine learning. The company specializes in creating advanced clinical tools designed to improve the accuracy of medical imaging and diagnostics for endoscopic procedures. By providing physicians with AI-driven systems, Iterative Health aims to boost detection rates, refine decision-making processes, and ultimately improve patient outcomes across various healthcare settings, thereby expanding access to high-quality medical services.
How much funding has Iterative Health raised?
Iterative Health has raised a total of $257M across 3 funding rounds:
Series A
$30M
Series B
$150M
Series C
$77M
Series A (2021): $30M with participation from Seae Ventures, Breyer Capital, Obvious Ventures, Eli Lilly, and Johnson & Johnson Innovation
Series B (2022): $150M led by Insight Partners, Eli Lilly, Johnson & Johnson, Obvious Ventures, Breyer Capital, and Clearlake Capital
Series C (2026): $77M supported by The Obvious, GV, Intrepid Growth Partners, Insight Partners, and EDBI
Key Investors in Iterative Health
The Obvious
The Obvious Corp is a creative and design firm specializing in strategic design, copywriting, and illustration, transforming client ideas into compelling marketing and communications materials across various formats and channels.
GV
GV is a venture capital firm investing across multiple stages and sectors, with a focus on enterprise solutions, life sciences, and frontier technology innovations globally.
Intrepid Growth Partners
Intrepid Growth Partners is a growth equity firm exclusively focused on supporting entrepreneurs who are leveraging AI.
What's next for Iterative Health?
The substantial enterprise-level backing positions Iterative Health for significant scaling and market expansion. The recent major strategic investment signals strong confidence from investors in the company's technology and its potential to disrupt the GI care landscape. This capital will likely fuel further research and development, enhance product integration into clinical workflows, and support broader market penetration. Iterative Health is poised to solidify its position as a leader in AI-powered medical diagnostics, driving innovation and improving patient care standards.
See full Iterative Health company page
